Literature DB >> 33931733

Cannabinoid receptor activation acutely increases synaptic vesicle numbers by activating synapsins in human synapses.

Christopher Patzke1,2, Jinye Dai3,4, Marisa M Brockmann5, Zijun Sun3, Pascal Fenske5, Christian Rosenmund5, Thomas C Südhof3,4.   

Abstract

Cannabis and cannabinoid drugs are central agents that are used widely recreationally and are employed broadly for treating psychiatric conditions. Cannabinoids primarily act by stimulating presynaptic CB1 receptors (CB1Rs), the most abundant G-protein-coupled receptors in brain. CB1R activation decreases neurotransmitter release by inhibiting presynaptic Ca2+ channels and induces long-term plasticity by decreasing cellular cAMP levels. Here we identified an unanticipated additional mechanism of acute cannabinoid signaling in presynaptic terminals that regulates the size of synaptic vesicle pools available for neurotransmitter release. Specifically, we show that activation of CB1Rs in human and mouse neurons rapidly recruits vesicles to nerve terminals by suppressing the cAMP-dependent phosphorylation of synapsins. We confirmed this unanticipated mechanism using conditional deletion of synapsin-1, the predominant synapsin isoform in human neurons, demonstrating that synapsin-1 significantly contributes to the CB1R-dependent regulation of neurotransmission. Interestingly, acute activation of the Gi-DREADD hM4D mimics the effect of CB1R activation in a synapsin-1-dependent manner, suggesting that the control of synaptic vesicle numbers by synapsin-1 phosphorylation is a general presynaptic mechanism of neuromodulation. Thus, we uncovered a CB1R-dependent presynaptic mechanism that rapidly regulates the organization and neurotransmitter release properties of synapses.
© 2021. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33931733     DOI: 10.1038/s41380-021-01095-0

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  38 in total

1.  Reduced cannabinoid CB1 receptor binding in alcohol dependence measured with positron emission tomography.

Authors:  J Hirvonen; P Zanotti-Fregonara; J C Umhau; D T George; D Rallis-Frutos; C H Lyoo; C-T Li; C S Hines; H Sun; G E Terry; C Morse; S S Zoghbi; V W Pike; R B Innis; M Heilig
Journal:  Mol Psychiatry       Date:  2012-07-10       Impact factor: 15.992

2.  Molecular composition of the endocannabinoid system at glutamatergic synapses.

Authors:  István Katona; Gabriella M Urbán; Matthew Wallace; Catherine Ledent; Kwang-Mook Jung; Daniele Piomelli; Ken Mackie; Tamás F Freund
Journal:  J Neurosci       Date:  2006-05-24       Impact factor: 6.167

3.  Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers.

Authors:  J Hirvonen; R S Goodwin; C-T Li; G E Terry; S S Zoghbi; C Morse; V W Pike; N D Volkow; M A Huestis; R B Innis
Journal:  Mol Psychiatry       Date:  2011-07-12       Impact factor: 15.992

Review 4.  Cannabinoids for Medical Use: A Systematic Review and Meta-analysis.

Authors:  Penny F Whiting; Robert F Wolff; Sohan Deshpande; Marcello Di Nisio; Steven Duffy; Adrian V Hernandez; J Christiaan Keurentjes; Shona Lang; Kate Misso; Steve Ryder; Simone Schmidlkofer; Marie Westwood; Jos Kleijnen
Journal:  JAMA       Date:  2015 Jun 23-30       Impact factor: 56.272

Review 5.  Endocannabinoid signaling and synaptic function.

Authors:  Pablo E Castillo; Thomas J Younts; Andrés E Chávez; Yuki Hashimotodani
Journal:  Neuron       Date:  2012-10-04       Impact factor: 17.173

6.  Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: a quantitative autoradiographic study.

Authors:  A Oviedo; J Glowa; M Herkenham
Journal:  Brain Res       Date:  1993-07-09       Impact factor: 3.252

Review 7.  Endocannabinoid-mediated retrograde modulation of synaptic transmission.

Authors:  Takako Ohno-Shosaku; Masanobu Kano
Journal:  Curr Opin Neurobiol       Date:  2014-04-18       Impact factor: 6.627

8.  Neuromodulator Signaling Bidirectionally Controls Vesicle Numbers in Human Synapses.

Authors:  Christopher Patzke; Marisa M Brockmann; Jinye Dai; Kathlyn J Gan; M Katharina Grauel; Pascal Fenske; Yu Liu; Claudio Acuna; Christian Rosenmund; Thomas C Südhof
Journal:  Cell       Date:  2019-10-03       Impact factor: 41.582

Review 9.  Deconstructing the neurobiology of cannabis use disorder.

Authors:  Jacqueline-Marie N Ferland; Yasmin L Hurd
Journal:  Nat Neurosci       Date:  2020-04-06       Impact factor: 28.771

10.  Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study.

Authors:  A Neumeister; M D Normandin; R H Pietrzak; D Piomelli; M Q Zheng; A Gujarro-Anton; M N Potenza; C R Bailey; S F Lin; S Najafzadeh; J Ropchan; S Henry; S Corsi-Travali; R E Carson; Y Huang
Journal:  Mol Psychiatry       Date:  2013-05-14       Impact factor: 15.992

View more
  7 in total

1.  Distinct neurexin-cerebellin complexes control AMPA- and NMDA-receptor responses in a circuit-dependent manner.

Authors:  Jinye Dai; Kif Liakath-Ali; Samantha Rose Golf; Thomas C Südhof
Journal:  Elife       Date:  2022-10-07       Impact factor: 8.713

Review 2.  The Endocannabinoids-Microbiota Partnership in Gut-Brain Axis Homeostasis: Implications for Autism Spectrum Disorders.

Authors:  Roberto Coccurello; Maria Cristina Marrone; Mauro Maccarrone
Journal:  Front Pharmacol       Date:  2022-06-03       Impact factor: 5.988

3.  Automated Detection and Localization of Synaptic Vesicles in Electron Microscopy Images.

Authors:  Barbara Imbrosci; Dietmar Schmitz; Marta Orlando
Journal:  eNeuro       Date:  2022-01-20

4.  Bassoon controls synaptic vesicle release via regulation of presynaptic phosphorylation and cAMP.

Authors:  Carolina Montenegro-Venegas; Debarpan Guhathakurta; Eneko Pina-Fernandez; Maria Andres-Alonso; Florian Plattner; Eckart D Gundelfinger; Anna Fejtova
Journal:  EMBO Rep       Date:  2022-06-29       Impact factor: 9.071

5.  Lactobacillus plantarum ST-III culture supernatant ameliorates alcohol-induced cognitive dysfunction by reducing endoplasmic reticulum stress and oxidative stress.

Authors:  Zeping Xu; Jinjing Zhang; Junnan Wu; Shizhuo Yang; Yuying Li; Yuyu Wu; Siyuan Li; Xie Zhang; Wei Zuo; Xiang Lian; Jianjun Lin; Yongsheng Jiang; Longteng Xie; Yanlong Liu; Ping Wang
Journal:  Front Neurosci       Date:  2022-09-14       Impact factor: 5.152

6.  Alcohol reverses the effects of KCNJ6 (GIRK2) noncoding variants on excitability of human glutamatergic neurons.

Authors:  Dina Popova; Isabel Gameiro-Ros; Mark M Youssef; Petronio Zalamea; Ayeshia D Morris; Iya Prytkova; Azadeh Jadali; Kelvin Y Kwan; Chella Kamarajan; Jessica E Salvatore; Xiaoling Xuei; David B Chorlian; Bernice Porjesz; Samuel Kuperman; Danielle M Dick; Alison Goate; Howard J Edenberg; Jay A Tischfield; Zhiping P Pang; Paul A Slesinger; Ronald P Hart
Journal:  Mol Psychiatry       Date:  2022-10-07       Impact factor: 13.437

7.  Transcriptomic Profiling in Mice With CB1 receptor Deletion in Primary Sensory Neurons Suggests New Analgesic Targets for Neuropathic Pain.

Authors:  Yongmin Liu; Min Jia; Caihua Wu; Hong Zhang; Chao Chen; Wenqiang Ge; Kexing Wan; Yuye Lan; Shiya Liu; Yuanheng Li; Mengyue Fang; Jiexi He; Hui-Lin Pan; Jun-Qiang Si; Man Li
Journal:  Front Pharmacol       Date:  2022-01-03       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.